General Information of the Compound
| Compound ID |
CP0504851
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Ac-His-D-Phe-Arg-4Pal-NH2
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H41N11O5
|
||||||||||||||||||
| Molecular Weight |
647.741
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](Cc1ccncc1)C(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H41N11O5/c1-19(43)39-26(16-22-17-36-18-38-22)30(47)42-25(15-20-6-3-2-4-7-20)29(46)40-23(8-5-11-37-31(33)34)28(45)41-24(27(32)44)14-21-9-12-35-13-10-21/h2-4,6-7,9-10,12-13,17-18,23-26H,5,8,11,14-16H2,1H3,(H2,32,44)(H,36,38)(H,39,43)(H,40,46)(H,41,45)(H,42,47)(H4,33,34,37)/t23-,24+,25-,26-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GVMPDJLBXVWWIQ-QYOOZWMWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02450, Melanocortin receptor 3
Protein ID: PT01431, Melanocortin receptor 4
Protein ID: PT01528, Melanocortin receptor 5
Protein ID: PT01440, Melanocyte-stimulating hormone receptor